Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk.
暂无分享,去创建一个
E. Thorland | N. Key | I. Warrier | S. Sommer | J. Lusher | A. Shapiro | M. Koerper | D. DiMichele | J. Drost | J. Westman